These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 7476093)
1. Experimental Chlamydia pneumoniae infection in mice: effect of reinfection and passive immunization. Kaukoranta-Tolvanen SE; Laurila AL; Saikku P; Leinonen M; Laitinen K Microb Pathog; 1995 Apr; 18(4):279-88. PubMed ID: 7476093 [TBL] [Abstract][Full Text] [Related]
2. Experimental infection of Chlamydia pneumoniae in mice. Kaukoranta-Tolvanen SS; Laurila AL; Saikku P; Leinonen M; Liesirova L; Laitinen K Microb Pathog; 1993 Oct; 15(4):293-302. PubMed ID: 8309355 [TBL] [Abstract][Full Text] [Related]
3. Protective DNA immunization against Chlamydia pneumoniae. Svanholm C; Bandholtz L; Castaños-Velez E; Wigzell H; Rottenberg ME Scand J Immunol; 2000 Apr; 51(4):345-53. PubMed ID: 10736106 [TBL] [Abstract][Full Text] [Related]
4. [Experimental study on the mechanisms of Chlamydia pneumoniae respiratory infection in mice with former chlamydial exposure]. Kimura M Kansenshogaku Zasshi; 1994 Jan; 68(1):50-8. PubMed ID: 8138679 [TBL] [Abstract][Full Text] [Related]
5. Local immune responses to Chlamydia pneumoniae in the lungs of BALB/c mice during primary infection and reinfection. Penttilä JM; Anttila M; Puolakkainen M; Laurila A; Varkila K; Sarvas M; Mäkelä PH; Rautonen N Infect Immun; 1998 Nov; 66(11):5113-8. PubMed ID: 9784511 [TBL] [Abstract][Full Text] [Related]
6. Depletion of CD8+ cells abolishes memory in acquired immunity against Chlamydia pneumoniae in BALB/c mice. Penttilä JM; Anttila M; Varkila K; Puolakkainen M; Sarvas M; Mäkelä PH; Rautonen N Immunology; 1999 Jul; 97(3):490-6. PubMed ID: 10447772 [TBL] [Abstract][Full Text] [Related]
7. Comparison of intranasal and transcutaneous immunization for induction of protective immunity against Chlamydia muridarum respiratory tract infection. Skelding KA; Hickey DK; Horvat JC; Bao S; Roberts KG; Finnie JM; Hansbro PM; Beagley KW Vaccine; 2006 Jan; 24(3):355-66. PubMed ID: 16153755 [TBL] [Abstract][Full Text] [Related]
8. Experimental Chlamydia pneumoniae infection in NIH/S mice: effect of reinoculation with chlamydial or cell preparation on culture, PCR and histological findings of lung tissue. Erkkilä L; Laitinen K; Laurila A; Saikku P; Leinonen M Vaccine; 2002 May; 20(17-18):2318-24. PubMed ID: 12009287 [TBL] [Abstract][Full Text] [Related]
9. Clearance of Chlamydia pneumoniae infection in H-2 class I human leucocyte antigen-A2.1 monochain transgenic mice. Tammiruusu A; Haveri A; Pascolo S; Lahesmaa R; Stevanovic S; Rammensee HG; Sarvas M; Puolakkainen M; Vuola JM Scand J Immunol; 2005 Aug; 62(2):131-9. PubMed ID: 16101819 [TBL] [Abstract][Full Text] [Related]
10. Intragastric primary infection sensitizes to lung reinfection in a Chlamydia pneumoniae mouse model. Erkkilä L; Saario E; Laitinen K; Saikku P; Leinonen M Vaccine; 2008 May; 26(20):2503-9. PubMed ID: 18433949 [TBL] [Abstract][Full Text] [Related]
11. Mast cells play an important role in chlamydia pneumoniae lung infection by facilitating immune cell recruitment into the airway. Chiba N; Shimada K; Chen S; Jones HD; Alsabeh R; Slepenkin AV; Peterson E; Crother TR; Arditi M J Immunol; 2015 Apr; 194(8):3840-51. PubMed ID: 25754739 [TBL] [Abstract][Full Text] [Related]
12. Chronic and repeated Chlamydophila pneumoniae lung infection can result in increasing IL-4 gene expression and thickness of airway subepithelial basement membrane in mice. Chen CZ; Yang BC; Lin TM; Lee CH; Hsiue TR J Formos Med Assoc; 2009 Jan; 108(1):45-52. PubMed ID: 19181607 [TBL] [Abstract][Full Text] [Related]
13. A mouse model of Chlamydia pneumoniae strain TWAR pneumonitis. Yang ZP; Kuo CC; Grayston JT Infect Immun; 1993 May; 61(5):2037-40. PubMed ID: 8478091 [TBL] [Abstract][Full Text] [Related]
14. Reactivation of Chlamydia pneumoniae infection in mice by cortisone treatment. Laitinen K; Laurila AL; Leinonen M; Saikku P Infect Immun; 1996 Apr; 64(4):1488-90. PubMed ID: 8606126 [TBL] [Abstract][Full Text] [Related]
15. Chlamydia, inflammation, and atherogenesis. Rosenfeld ME; Blessing E; Lin TM; Moazed TC; Campbell LA; Kuo C J Infect Dis; 2000 Jun; 181 Suppl 3():S492-7. PubMed ID: 10839746 [TBL] [Abstract][Full Text] [Related]
16. Evidence of systemic dissemination of Chlamydia pneumoniae via macrophages in the mouse. Moazed TC; Kuo CC; Grayston JT; Campbell LA J Infect Dis; 1998 May; 177(5):1322-5. PubMed ID: 9593019 [TBL] [Abstract][Full Text] [Related]
17. Role of innate and adaptive immunity in the outcome of primary infection with Chlamydia pneumoniae, as analyzed in genetically modified mice. Rottenberg ME; Gigliotti Rothfuchs AC; Gigliotti D; Svanholm C; Bandholtz L; Wigzell H J Immunol; 1999 Mar; 162(5):2829-36. PubMed ID: 10072530 [TBL] [Abstract][Full Text] [Related]
18. Gene expression signatures characterizing the development of lymphocyte response during experimental Chlamydia pneumoniae infection. Kyläniemi MK; Haveri A; Vuola JM; Puolakkainen M; Lahesmaa R Microb Pathog; 2009 May; 46(5):235-42. PubMed ID: 19486640 [TBL] [Abstract][Full Text] [Related]
19. The pathogenesis of Chlamydia pneumoniae-type pneumonitis in mice. Shi Y; Yin J; Zhan H; Feng G; Zhang X; Su X; Song Y; Xia X; Zhou X; Shen P Chin Med J (Engl); 2003 Mar; 116(3):328-32. PubMed ID: 12781030 [TBL] [Abstract][Full Text] [Related]
20. IL-12 administered during Chlamydia psittaci lung infection in mice confers immediate and long-term protection and reduces macrophage inflammatory protein-2 level and neutrophil infiltration in lung tissue. Huang J; Wang MD; Lenz S; Gao D; Kaltenboeck B J Immunol; 1999 Feb; 162(4):2217-26. PubMed ID: 9973497 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]